Update on adrenergic agents in glaucoma therapy

M. S. Juzych, T. J. Zimmerman, A. L. Robin

Research output: Contribution to journalReview articlepeer-review


Ocular pharmacologists have developed various pharmaceutical agents with applications in the treatment of glaucoma by recognizing the potential to lower intraocular pressure by manipulating adrenergic receptors. This article discusses the therapeutic use and effects of adrenergic agents in glaucoma therapy, including α-2 agonist, brimonidine, β-blockers, timolol, betaxolol, carteolol, levobunolol, and metipranolol.

Original languageEnglish (US)
Pages (from-to)309-325
Number of pages17
JournalOphthalmology Clinics of North America
Issue number3
StatePublished - Oct 29 1997
Externally publishedYes

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Update on adrenergic agents in glaucoma therapy'. Together they form a unique fingerprint.

Cite this